Table 4.
Odds ratios of having prescription drugs for males, compared to females, after adjustment for age, multi-morbidity and relevant prescription drug in univariate analyses (Model 2)
| Prescription drug excluded from the analysis | OR (95% CI) | P-value |
|---|---|---|
| NSAIDs |
0.44 (0.43-0.45) |
<0.001 |
| Buspirone |
0.45 (0.45-0.46) |
<0.001 |
| Coxibs |
0.45 (0.45-0.46) |
<0.001 |
| Inhalable corticosteroids |
0.45 (0.45-0.46) |
<0.001 |
| Ipratropium |
0.45 (0.45-0.46) |
<0.001 |
| Selective beta-2 stimulants |
0.45 (0.44-0.46) |
<0.001 |
| Antidepressants |
0.46 (0.45-0.47) |
<0.001 |
| Benzodiazepines |
0.46 (0.45-0.46) |
<0.001 |
| Benzodiazepine-related drugs |
0.46 (0.45-0.47) |
<0.001 |
| Derivatives of benzodiazepines |
0.46 (0.45-0.46) |
<0.001 |
| Hydroxyzine |
0.46 (0.45-0.46) |
<0.001 |
| Migraine drugs |
0.46 (0.45-0.47) |
<0.001 |
| Nitrofurantoin |
0.46 (0.45-0.47) |
<0.001 |
| Paracetamol |
0.46 (0.45-0.47) |
<0.001 |
| Propiomazine |
0.46 (0.45-0.46) |
<0.001 |
| Trimethoprim |
0.46 (0.45-0.47) |
<0.001 |
| Estrogens |
0.47 (0.46-0.48) |
<0.001 |
| Gestagens |
0.47 (0.46-0.48) |
<0.001 |
| Pivmecillinam |
0.47 (0.46-0.48) |
<0.001 |
| Thyroid hormones |
0.47 (0.46-0.48) |
<0.001 |
| Anti-conception drugs | 0.65 (0.64-0.66) | <0.001 |